Invited commentary

Annals of Thoracic Surgery

Volumn 84, Issue 1, 2007, Pages 168-169

  Welsby, Ian J ^a   Ortel, Thomas L ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLOOD TRANSFUSION; DRAIN; EXTRACORPOREAL OXYGENATION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; MORBIDITY; MORTALITY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE; THROMBOSIS;

EID: 34250670451     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.04.021     Document Type: Note

References (2)

1. Agarwal H.S., Bennett J.E., Churchwell K.B., et al. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. Ann Thorac Surg 84 (2007) 161-169
2. O'Connell K.A., Wood J.J., Wise R.P., Lozier J.N., and Braun M.M. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295 (2006) 293-298